Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services

Susan D. Whitley, Hillary V. Kunins, Julia H. Arnsten, Marc N. Gourevitch

Research output: Contribution to journalArticlepeer-review


Buprenorphine may be used to treat opioid dependence in office-based settings, but treatment models are needed to ensure access to psychosocial services needed by many patients. We describe a novel buprenorphine treatment program colocated with methadone maintenance and outpatient chemical dependency services. We conducted a retrospective chart review of the first 40 consecutive patients initiating buprenorphine treatment in this program to determine characteristics associated with treatment retention. Exclusion criteria were current alcohol or benzodiazepine dependence. Secondary drug users and patients who were psychiatrically or medically ill were included. At 6 months, 60% (n = 24) were retained, 13% (n = 5) tested positive for opiates, and 25% (n = 10) tested positive for secondary substances. Patients who were older (odds ratio [OR] per year of age = 1.1, confidence interval [CI] = 1.0-1.2) and those who were employed (OR = 9.8, CI = 1.8-53.1) were more likely to remain in treatment, but other variables were not associated with retention. Our experience demonstrates that buprenorphine can be successfully integrated into outpatient substance abuse treatment.

Original languageEnglish (US)
Pages (from-to)85-90
Number of pages6
JournalJournal of Substance Abuse Treatment
Issue number1
StatePublished - Jul 2007


  • Buprenorphine
  • Chemical dependency
  • Drug users
  • Methadone
  • Opioid dependence

ASJC Scopus subject areas

  • Phychiatric Mental Health
  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health


Dive into the research topics of 'Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services'. Together they form a unique fingerprint.

Cite this